Alzheimer Disease: all 3,765 studies
Page 33 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's DiseaseCompletedNCT01320527Phase 2
- Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related DisordersStatus unknownNCT01316562
- Gait and Alzheimer Interaction Tracking (GAIT) StudyCompletedNCT01315717
- Alzheimer's Disease and Related DisordersStatus unknownNCT01315704
- New Biomarker for Alzheimer's Disease DiagnosticCompletedNCT01315639Not applicable
- Alzheimer's Disease Multiple Intervention TrialCompletedNCT01314950Not applicable
- Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio)Status unknownNCT01314638
- Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing HomeStatus unknownNCT01314131Not applicable
- Study of Magnetic Fields to Treat Alzheimer's DiseaseWithdrawnNCT01313806Not applicable
- Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) PatientsCompletedNCT01312363
- Exercise Trial for Alzheimer's DiseaseCompletedNCT01311492Not applicable
- Safety and Tolerability of AFFITOPE AD03CompletedNCT01309763Phase 1
- The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's DiseaseCompletedNCT01297218Phase 1
- The PACO Study ("Personnalité Alzheimer COmportement")Status unknownNCT01297140Not applicable
- Imaging of Cognition, Learning, and Memory in AgingCompletedNCT01297114
- Pharmacokinetic Comparisons of Two Donepezil FormulationsCompletedNCT01297036Phase 1
- Alzheimer's Disease Reminiscence Quality of LifeCompletedNCT01295957Phase 4
- Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly CohortCompletedNCT01294540Phase 1
- Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT01284387Phase 2
- Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's DiseaseStatus unknownNCT01282619Phase 2/3
- Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their CaregiversCompletedNCT01273272Phase 2
- Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HCCompletedNCT01268020Early Phase 1
- Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on DonepezilCompletedNCT01266525Phase 2
- Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male SubjectsCompletedNCT01258452Phase 1
- Study of STA-1 as an Add-on Treatment to DonepezilStatus unknownNCT01255046Phase 2
- Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT01254773Phase 2
- Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's DiseaseCompletedNCT01254448Phase 1
- Multiple Dose Study of TRx0037CompletedNCT01253499Phase 1
- Comparative Bioavailability in Healthy Elderly VolunteersCompletedNCT01253122Phase 1
- Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseCompletedNCT01251718
- A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseCompletedNCT01249196Phase 3
- An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type DementiaCompletedNCT01245530Phase 3
- Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy VolunteersStatus unknownNCT01238458Phase 2
- Alzheimer's Disease Neuroimaging Initiative 2CompletedNCT01231971
- Isotopic Imaging for Prodromal Alzheimer's DiseaseCompletedNCT01231295
- A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose StudyCompletedNCT01230853Phase 1
- AD01 Follow up Extension VisitCompletedNCT01225809
- A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy SubjectsCompletedNCT01221259Phase 1
- Collaboration Between Department of Old Age Psychiatry and Nursing HomesCompletedNCT01217541Not applicable
- Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558CompletedNCT01217021Early Phase 1
- AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)WithdrawnNCT01211782Phase 2/3
- Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological ConditionsCompletedNCT01209156Phase 1
- The Swedish BioFINDER StudyCompletedNCT01208675
- Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male SubjectsCompletedNCT01203384Phase 1
- Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)Status unknownNCT01198093
- Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's DiseaseStatus unknownNCT01195389Not applicable
- Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) DynamicsCompletedNCT01194713Not applicable
- Evaluation of a Diet in Patients With Senile DementiaStatus unknownNCT01192529Not applicable
- Capacity Assessment in Persons With Alzheimer's DiseaseCompletedNCT01190800
- Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's DiseaseCompletedNCT01189084
- Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease PatientsCompletedNCT01183806Phase 3
- Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's DiseaseCompletedNCT01179373Phase 2
- TMS Stimulation and Cognitive Training in Alzheimer PatientsCompletedNCT01168245Phase 1
- Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease PatientsStatus unknownNCT01163825Phase 1
- Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy VolunteersCompletedNCT01153607Phase 1
- An Extension of the CONCERT Protocol (DIM18)TerminatedNCT01152216Phase 3
- A Biomarker Study of Solanezumab in Patients With and Without Alzheimer'sCompletedNCT01148498Phase 2
- Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and ControlsStatus unknownNCT01147679
- Non Pharmacological Treatment in Alzheimer's Disease and Associated DisordersTerminatedNCT01143350Not applicable
- Trazodone for Sleep Disorders in Alzheimer's DiseaseCompletedNCT01142258Phase 3
- The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic PatientsTerminatedNCT01137799Phase 1
- Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's DiseaseCompletedNCT01137526Phase 2
- Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-CompletedNCT01129596
- Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological MarkersStatus unknownNCT01128725Not applicable
- To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's DiseaseTerminatedNCT01125683Phase 2
- Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT01125631Phase 1
- Screening for Memory StudiesCompletedNCT01123018
- A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's DiseaseCompletedNCT01122329Phase 4
- Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's DiseaseStatus unknownNCT01120002Phase 2
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's DiseaseCompletedNCT01117818Phase 2
- Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's DiseaseStatus unknownNCT01099332Phase 1/2
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedNCT01097096Phase 2
- Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's DiseaseCompletedNCT01095744
- Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer DiseaseStatus unknownNCT01095718Not applicable
- Thalidomide for Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT01094340Phase 2/3
- Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's DiseaseCompletedNCT01094145Not applicable
- Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02CompletedNCT01093664Phase 1
- Effectiveness of Care Management in Alzheimer PatientsCompletedNCT01081743Not applicable
- Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163CompletedNCT01079819Phase 1
- Alzheimer's Disease Neuroimaging Initiative Grand OpportunityCompletedNCT01078636
- Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01073228Phase 2
- Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive ImpairmentTerminatedNCT01072812Phase 1
- Safety and Tolerability of Etanercept in Alzheimer's DiseaseCompletedNCT01068353Phase 2
- A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's DiseaseWithdrawnNCT01066481Phase 2
- Sensory-cognitive and Physical Fitness Training in Mild Cognitive ImpairmentCompletedNCT01061489Not applicable
- Multiple Dose Japanese Bridging StudyCompletedNCT01057030Phase 1
- A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of DementiaCompletedNCT01055561Phase 1
- Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's DiseaseStatus unknownNCT01055392Phase 2
- Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental ResearchCompletedNCT01049555Not applicable
- A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's DiseaseCompletedNCT01047579Phase 4
- Bupropion for the Treatment of Apathy in Alzheimer's DementiaCompletedNCT01047254Phase 3
- Drug-Drug Interaction Study With Aricept® (Donepezil)CompletedNCT01042314Phase 1
- 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01039701Phase 2
- Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)CompletedNCT01039194Phase 1
- Effects of Exercise and Cognitive Training on Cognitive Function in Older AdultsCompletedNCT01038726Not applicable
- Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy VolunteersCompletedNCT01035164Phase 1
- Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological ConditionsTerminatedNCT01028209Phase 1
- Exelon Patch and Combination With Memantine Comparative TrialCompletedNCT01025466Phase 4
- The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With DonepezilCompletedNCT01024660Early Phase 1